NeuroOne Medical Technologies (NMTC) shares rose more than 9% in recent trading Friday after it said it expects fiscal Q1 revenue of $6.2 million, up from $1 million a year earlier.
The company said the quarter ended Dec. 31, 2024, includes a one-time $3 million payment of collaboration revenue from the expanded distribution deal with Zimmer Biomet Holdings (ZBH) for commercialization of NeuroOne's OneRF Ablation System.
Price: 1.17, Change: +0.10, Percent Change: +9.35
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.